Fataneh Majlessipour, MD
5.0
4 Reviews
310-423-4423
Fax: 310-967-1141
5.0
4 Reviews
Fataneh Majlessipour, MD
Scheduling
In person visits
Fax: 310-967-1141
Samuel Oschin Cancer Center
127 S San Vicente Blvd - 7th Floor
Los Angeles, CA
34.074713 -118.379418From You
5.0
4 Reviews
Fataneh Majlessipour, MD
Languages
- English,
- Farsi,
Gender
Female
Experience
32 Years
Locations
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Peds Hematology Oncology
Programs
Cedars-Sinai clinical programs this provider is part of:
3
Titles
- Director, Division of Pediatric Hematology/Oncology
Education & Training
-
Children's Hospital Los Angeles
Residency - Completed 2000
-
Children's Hospital of Orange County
Residency - Completed 1997
-
Isfahan University of Medical Sciences Iran
Medical School - Completed 1990
Achievements
-
2
Board Certifications
-
4
Awards and Honors
-
8
Publications
Board Certifications
-
Pediatrics
American Board of Pediatrics
-
Pediatric Hematology-Oncology
American Board of Pediatrics
Awards and Honors
- Hollywood Top Doctors
- Southern California Super Doctors
- Best Doctors of Los Angeles
- Los Angeles Top Doctors
Publications
A full list of this provider’s research publications can be found on their research profile or PubMed.
- Chan, J, Kashanian, A, Bannykh, S, Majlessipour, F, Breunig, J, Danielpour, M RELA Fusion-Positive Ependymoma in a Child with Down Syndrome: Case Report. Accepted in August 2020 for publication in Pediatric Neurosurgery.
- Rao RR, Majlessipour F, Ziring DA, Baca NM. Ewing's Sarcoma in a Patient with Crohn's Disease Treated with Ustekinumab: A Case Report. J Adolesc Young Adult Oncol. 2020 Sep 22. doi: 10.1089/jayao.2020.0077.
- Miller JM, Wachsman A, Haker K, Majlessipour F, Danielpour M, Puliyanda D. The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanent. Pediatr Nephrol. 2015 Jan; 30(1):173-7.
- . Gidrewics D, Rabizadeh S, Lehman D, Majlessipour F, Dubinsky M. Primary EBV infection resulting in Lymphoproliferative disease in a teenager with Crohn’s disease. Journal of Pediatric Gastroenterology & Nutrition, 2010
- Baron PW, Majlessipour F, Bedros AA, Zuppan CW, Ben-Youssef R, Yanni G, Ojogho ON, and Concepcion W. Undifferentiated Embryonal sarcoma of the liver successfully treated with chemotherapy; and liver resection. J of Gastrointestinal Surgery Vol11, Number 1, January 2007, pages: 73-75
- Avramis VI, Sencer S, Periclou P, Sather H, Bostrom B, Cohen LJ, Ettinger AG, Ettinger LJ, Franklin J, Gaynon P, Hilden JM, Lange B, Majlessipour F, Pracad M, Needle M, Neglia J, Reaman G, Holcenberg JS. A randomized comparison of Native E. Coli asparaginase and polyethylene glycol conjugated asparaginase for the treatment of children with newly diagnosed standard-risk acute lymphoblastic Leukemia: A Children’s Cancer Group study. Blood 99(6):1986-1994 (2002).
- Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avramis VI. The Combination Regimen of Idarubicin and Taxotere is effective Against Human Drug-Resistant Leukemic Cell Lines. Anticancer Research 22:1361-1368 (2002).
- Majlessipour F, Kwock R, Martin-Aragon S, Weinberg KI, Avramis VI. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities. Anticancer Research 21:11-22 (2001).